Your search returned 8 results.

Results
	1.	Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry. MedStar authors: Sugarbaker, Paul H PMID: 29260418 Year: 2018 Citation: Annals of Surgical Oncology. 25(3):667-673, 2018 Mar. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Baratti D, Chouliaras K, De Simone M, Deraco M, Elias D, Glehen O, Heyd B, Kusamura S, Levine EA, Morris D, RENAPE Working Group, Robella M, Russell G, Shen P, Sugarbaker P, Votanopoulos KI DOI: https://dx.doi.org/10.1245/s10434-017-6293-5 Add to cart (remove)
	2.	Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. MedStar authors: Swain, Sandra M PMID: 23940225 Year: 2013 Citation: Journal of Clinical Oncology. 31(26):3197-204, 2013 Sep 10. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Atkins JN, Azar CA, Biggs DD, Brufsky AM, Costantino JP, Donnellan PP, Fehrenbacher L, Geyer CE Jr, Levine EA, Mamounas EP, Northfelt DW, Paik S, Polikoff JA, Provencher L, Rastogi P, Robidoux A, Swain SM, Tang G, Wolmark N, Zapas JL DOI: http://dx.doi.org/10.1200/JCO.2012.48.1275 Add to cart (remove)
	3.	Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent or progressive diffuse malignant peritoneal mesothelioma: clinicopathologic characteristics and survival outcome. MedStar authors: Bijelic, Lana Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 25120250 Year: 2015 Citation: Annals of Surgical Oncology. 22(5):1680-5, 2015 May. Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bijelic L, Ihemelandu C, Sugarbaker PH DOI: http://dx.doi.org/10.1245/s10434-014-3977-y Add to cart (remove)
	4.	Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades. MedStar authors: Ihemelandu, Chukwuemeka Sugarbaker, Paul H PMID: 27878480 Year: 2017 Citation: Annals of Surgical Oncology. 24(4):898-905, 2017 Apr Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Surgery/General Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Ihemelandu C, Sugarbaker PH DOI: https://dx.doi.org/10.1245/s10434-016-5698-x Add to cart (remove)
	5.	Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2. MedStar authors: Swain, Sandra M Zapas, John L PMID: 29072977 Year: 2017 Citation: Journal of Clinical Oncology. 35(35):3942-3948, 2017 Dec 10 Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins JN, Biggs DD, Brufsky AM, Cecchini RS, Fehrenbacher L, Flynn PJ, Ganz PA, Geyer CE Jr, Gross HM, Jeong JH, Mamounas EP, Polikoff J, Rastogi P, Romond EH, Seay TE, Swain SM, Wade JL 3rd, Wahl TA, Wolmark N, Zapas JL DOI: https://dx.doi.org/10.1200/JCO.2017.74.1165 Add to cart (remove)
	6.	Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). MedStar authors: Swain, Sandra M PMID: 28398846 Year: 2017 Citation: Journal of Clinical Oncology. 35(23):2647-2655, 2017 Aug 10. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Randomized Controlled Trial Form of publication: Journal Article All authors: Asmar L, Blum JL, Brufsky AM, Colangelo LH, Dang CT, Fehrenbacher L, Flynn PJ, Geyer CE Jr, Gomez HL, Hopkins JO, Jacobs SA, Jeong JH, Jones SE, Lyss AP, Mamounas EP, O'Shaughnessy JA, Paul D, Robert NJ, Swain SM, Vukelja SJ, Wolmark N, Yothers G DOI: https://dx.doi.org/10.1200/JCO.2016.71.4147 Add to cart (remove)
	7.	Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors: Swain, Sandra M PMID: 27693116 Year: 2017 Citation: Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N DOI: https://dx.doi.org/10.1016/j.clbc.2016.07.008 Add to cart (remove)
	8.	Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. MedStar authors: Swain, Sandra M PMID: 22393101 Year: 2012 Citation: Journal of Clinical Oncology. 30(12):1268-73, 2012 Apr 20. Institution: Washington Cancer Institute Medline publication type: Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Allred DC, Anderson SJ, Costantino JP, Geyer CE Jr, Julian TB, Land SR, Mamounas EP, Nagtegaal ID, Paik S, Swain SM, Wickerham DL, Wolmark N DOI: http://dx.doi.org/10.1200/JCO.2010.34.0141 Add to cart (remove)

Powered by Koha